Bone marrow-derived mesenchymal stem cells (MSCs) are known to be producers of SDF-1α [12], infiltrate glioblastoma tumors and have affinity for CD133-positive GSCs [76,77,78,79]. The gene discussed is CXCL12; the disease is glioblastoma.